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The painDETECT questionnaire was speciﬁcally 
developed to detect neuropathic pain components in adult 
patients with low back pain (Freynhagen et al 2006) and 
is recommended for use by non-specialists (Gaufﬁn et al 
2013). The original validation study included a large sample 
(n = 411) of patients with chronic pain recruited from ten 
specialised pain centres. The questionnaire was compared 
to the current gold standard – diagnosis by an expert pain 
physician. The painDETECT questionnaire is available 
from the original publication (Freynhagen et al 2006).
Instructions and scoring: The questionnaire consists of 
seven questions that address the quality of neuropathic pain 
symptoms; it is completed by the patient and no physical 
examination is required. The ﬁrst ﬁve questions ask about 
the gradation of pain, scored from 0 to 5 (never = 0, hardly 
noticed = 1, slightly = 2; moderately = 3, strongly = 4, 
very strongly = 5). Question 6 asks about the pain course 
pattern, scored from –1 to 2, depending on which pain 
course pattern diagram is selected. Question 7 asks about 
radiating pain, answered as yes or no, and scored as 2 or 0 
respectively. The ﬁnal score between –1 and 38, indicates 
the likelihood of a neuropathic pain component. A score 
of ) 12 indicates that pain is unlikely to have a neuropathic 
component (< 15%), while a score of * 19 suggests that 
pain is likely to have a neuropathic component (> 90%). 
A score between these values indicates that the result is 
uncertain and a more detailed examination is required to 
ensure a proper diagnosis (Freynhagen et al 2006). Since its 
development, four additional questions have been added to 
the painDETECT but do not contribute to the scoring. They 
ask the patient to rate their pain now and over the last four 
weeks, and to mark on a body chart if there is pain radiating 
into other parts of the body.
Reliability, validity and sensitivity to change: There are 
only a few studies investigating the clinimetric properties 
of the painDETECT questionnaire and they show it is a 
good screening tool to detect a neuropathic pain component 
in patients with low back pain. It has excellent test-retest 
reliability (ICC = 0.93) and good internal consistency 
(Cronbach’s alpha > 0.83) (Freynhagen et al 2006, De 
Andres et al 2012). The electronic and paper version of 
the questionnaire demonstrated high criterion validity, 
compared to the reference standard of an expert pain 
physician, indicated by high sensitivity, speciﬁcity, and 
positive predictive value (all > 80%) (Freynhagen et al 
2006). However, when the questionnaire was used in 
patients with ﬁbromyalgia, criterion validity was not 
as good (sensitivity 79%, speciﬁcity 53% and positive 
predictive value 46%, Gaufﬁn et al 2013). This indicates 
that the questionnaire may not be suited for use in other 
musculoskeletal conditions. It has been used as an outcome 
measure but the responsiveness or sensitivity to change has 
not been assessed.
Commentary
Neuropathic pain is a common clinical presentation that 
is often under-diagnosed and under-treated. Neuropathic 
pain is produced by injuries or diseases affecting the 
somatosensory system and can manifest in disease states 
affecting the central and peripheral nervous system 
(Haanpaa and Treede 2010). Patients with neuropathic pain 
usually have severe, chronic symptoms that affect their 
quality of life and are often difﬁcult to manage. This may be 
due to poor diagnosis or the presence of mixed pain states, 
ie, neuropathic pain plus nociceptive pain (De Andres et 
al 2012). Correct identiﬁcation of neuropathic pain enables 
a more direct and specialised management strategy for 
these patients, and screening tools aid in the diagnosis. 
The painDETECT questionnaire is a quick, simple and 
reliable screening tool to identify the likelihood of a 
neuropathic pain component in patients with low back pain. 
Its sensitivity and speciﬁcity is higher than other screening 
questionnaires for neuropathic pain, including the Douleur 
Neuropathique 4 (DN4), Leeds Assessment of Neuropathic 
Symptoms and Signs (LANNS), and the Neuropathic Pain 
Questionnaire (NPQ) (Freynhagen et al 2006).
The painDETECT questionnaire has been used to identify 
neuropathic pain in patients with knee osteoarthritis (Ohtori 
et al 2012) and to identify sensory proﬁles in patients with 
diabetic neuropathy and postherpetic neuralgia (Baron et al 
2009). However, further research is needed to demonstrate 
its clinimetric properties in these conditions.
The painDETECT questionnaire, in either the electronic 
or paper format, is a useful tool for clinicians, to screen 
for neuropathic pain in patients with low back pain and aid 
in patient management. Screening tools should not replace 
clinical judgment but can alert clinicians of neuropathic 
pain that may need further diagnostic evaluation.
Stephanie Mathieson and Christine Lin
Musculoskeletal Division, The George Institute for Global 
Health
References
Baron R et al (2009) Pain 146: 34–40.
De Andres J et al (2012) Clin J Pain 28: 243–253.
Freynhagen R et al (2006) Curr Med Res Opin 22: 1911–1920.
Gaufﬁn J et al (2013) BMC Neurology 13: 21–26.
Haanpaa M, Treede RD (2010) Pain Clinical Updates XVIII: 1–6.
Ohtori S et al (2012) Yonsei Med J 53: 801–805.
